Ticker
NBYCompany Name
NOVABAY PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 3.32M | 69.98% | $ 4.75M |
3/31/2025 | $ 3.66M | 51.2% | $ 7.15M |
12/31/2024 | $ -7.22M | -73.85% | $ 9.78M |
9/30/2024 | $ -10.12M | -90.36% | $ 11.2M |
6/30/2024 | $ -10.66M | -88.7% | $ 12.02M |
3/31/2024 | $ -11.12M | -78.09% | $ 14.23M |
12/31/2023 | $ -9.64M | -65.46% | $ 14.73M |
9/30/2023 | $ -13.74M | -93.83% | $ 14.64M |
6/30/2023 | $ -12.12M | -79.7% | $ 15.2M |
3/31/2023 | $ -12.24M | -89.72% | $ 13.64M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for NOVABAY PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -11.97M ] / Revenues [ $ 9.75M ]
(=) EBIT % [ -122.74% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |